Accounting revenue for FY17 is same as Q1FY18 cash revenue. Exponential growth here. Can't shake the feeling that the run-up will be short-lived though, as per the last few announcements.
- Forums
- ASX - By Stock
- BIG
- Ann: September 2017 Quarter Market Update
Ann: September 2017 Quarter Market Update, page-5
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online